Currently predicting for Thu, 4 Jun 2026

GERN Prediction Chart

GERN Predictions History

Latest community submissions for GERN.
Predictor Target Session Target Price Result Direction Accuracy Score
Jun 7, 2024 $3.80 -2.20% $4.59 X 82.89% 0
Jun 7, 2024 $3.84 -1.37% $4.59 X 83.59% 0
Jun 7, 2024 Bullish $4.59 V 1
Mar 22, 2024 $3.25 -2.29% $3.31 V 98.30% 1
Mar 22, 2024 $3.21 -3.66% $3.31 V 96.92% 1
Mar 22, 2024 Bearish $3.31 V 1
Dec 18, 2023 $2.20 -2.39% $2.17 V 98.79% 2
Dec 18, 2023 $2.22 -1.49% $2.17 V 97.86% 1
Dec 18, 2023 $5.05 +124.44% Unrealistic Excluded from avg $2.17 X 0.00% 0
Jul 7, 2023 $3.20 +1.98% $3.14 X 98.02% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for GERN with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT GERON CORPORATION
Geron
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hematologic myeloid malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes a...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE